Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Oligoastrocytoma”

91 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 91 results

Testing effectiveness (Phase 2)Study completedNCT00041587
What this trial is testing

Pre-operative IL13-PE38QQR in Patients With Recurrent or Progressive Malignant Glioma

Who this might be right for
Malignant GliomaGlioblastoma MultiformeAnaplastic Astrocytoma+1 more
INSYS Therapeutics Inc 80
Early research (Phase 1)Active Not RecruitingNCT07031765
What this trial is testing

Peds CHAMP1ON - Hematopoietic Stem Cell And Monoclonal Antibody PD-1 Blockade for RecurreNt Pediatric High-Grade Glioma

Who this might be right for
Recurrent High-grade GliomaGrade III AstrocytomaOligodendroglioma+3 more
University of Florida 12
Early research (Phase 1)Study completedNCT02015819
What this trial is testing

Genetically Modified Neural Stem Cells, Flucytosine, and Leucovorin for Treating Patients With Recurrent High-Grade Gliomas

Who this might be right for
Adult Anaplastic AstrocytomaAdult Anaplastic OligodendrogliomaAdult Giant Cell Glioblastoma+4 more
City of Hope Medical Center 16
Not applicableStudy completedNCT02903784
What this trial is testing

Neural Basis of Language Processing

Who this might be right for
OligoastrocytomaAstrocytomaOligodendroglioma
University Hospital, Montpellier 63
Not applicableUnknownNCT01089244
What this trial is testing

FET-PET for Diagnosis and Monitoring in Patients With Low Grade Glioma

Who this might be right for
AstrocytomaOligoastrocytomaOligodendroglioma
Ludwig-Maximilians - University of Munich 38
Not applicableUnknownNCT02795364
What this trial is testing

Study About the Validity of MRS-guided Resection on Prognosis High-grade Glioma Gliomas

Who this might be right for
GliomaAnaplastic OligoastrocytomaGlioblastomas (GBM)
Huashan Hospital 50
Testing effectiveness (Phase 2)Ended earlyNCT00389090
What this trial is testing

A Phase II Study of Temozolomide and O6-Benzylguanine (O6-BG) in Patients With Temozolomide-Resistant Anaplastic Glioma

Who this might be right for
GliomaAstrocytomaOligodendroglioma+1 more
Keryx / AOI Pharmaceuticals, Inc. 32
Very early researchStudy completedNCT00874861
What this trial is testing

HLA-A2-Restricted Glioma Antigen-Peptides Vaccinations With Poly-ICLC for Recurrent WHO Grade II Gliomas

Who this might be right for
AstrocytomaOligoastrocytomaOligodendroglioma
Ian F. Pollack, M.D. 10
Early research (Phase 1)Study completedNCT00031083
What this trial is testing

Dose Escalation Study to Determine the Safety of IFN-Beta Gene Transfer in the Treatment of Grade III & Grade IV Gliomas

Who this might be right for
Glioblastoma MultiformeAnaplastic AstrocytomaOligoastrocytoma, Mixed+1 more
Biogen 12
Testing effectiveness (Phase 2)Study completedNCT00165360
What this trial is testing

Prolonged Daily Temozolomide for Low-Grade Glioma

Who this might be right for
GliomaAstrocytomaOligodendroglioma
Dana-Farber Cancer Institute 46
Testing effectiveness (Phase 2)Study completedNCT02530320
What this trial is testing

Safety and Efficacy of PD0332991 (Palbociclib), a Cyclin-dependent Kinase 4 and 6 Inhibitor, in Patients With Oligodendroglioma or Recurrent Oligoastrocytoma Anaplastic With the Activity of the Protein RB Preserved

Who this might be right for
OligodendrogliomaOligoastrocytoma
Grupo Español de Investigación en Neurooncología 34
Early research (Phase 1)Ended earlyNCT02168270
What this trial is testing

Temozolomide and Ascorbic Acid in Treating Patients With Recurrent High-Grade Glioma

Who this might be right for
Anaplastic AstrocytomaAnaplastic OligodendrogliomaAnaplastic Oligoastrocytoma+2 more
University of Nebraska 4
Testing effectiveness (Phase 2)Study completedNCT01380782
What this trial is testing

BIBF 1120 for Recurrent High-Grade Gliomas

Who this might be right for
GlioblastomaGliosarcomaAnaplastic Astrocytoma+2 more
Patrick Y. Wen, MD 37
Testing effectiveness (Phase 2)Study completedNCT01847235
What this trial is testing

Temozolomide in Relapsed or Advanced Anaplastic Oligodendroglioma and Oligoastrocytoma: Single-arm, Phase II Trial

Who this might be right for
Anaplastic OligodendrogliomaAnaplastic Oligoastrocytoma
Seoul National University Hospital 23
Testing effectiveness (Phase 2)Study completedNCT00400816
What this trial is testing

Temozolomide in Treating Patients With Newly Diagnosed Anaplastic Oligodendroglioma or Mixed Oligoastrocytoma

Who this might be right for
Central Nervous System TumorsBrain Tumor
The Cleveland Clinic 29
Early research (Phase 1)Study completedNCT00611728
What this trial is testing

Ph I SU011248 + Irinotecan in Treatment of Pts w MG

Who this might be right for
Glioblastoma
Duke University 25
Testing effectiveness (Phase 2)Study completedNCT00671970
What this trial is testing

Phase (Ph) II Bevacizumab + Erlotinib for Patients (Pts) With Recurrent Malignant Glioma (MG)

Who this might be right for
GlioblastomaGliosarcoma
Duke University 57
Early research (Phase 1)Ended earlyNCT01339039
What this trial is testing

Plerixafor (AMD3100) and Bevacizumab for Recurrent High-Grade Glioma

Who this might be right for
High Grade Glioma: Glioblastoma (GBM)High Grade Glioma: GliosarcomaAnaplastic Astrocytoma (AA)+2 more
Patrick Y. Wen, MD 26
Large-scale testing (Phase 3)UnknownNCT02629757
What this trial is testing

A Study on β-elemene as Maintain Treatment for Newly Diagnosed Malignant Gliomas

Who this might be right for
Anaplastic OligoastrocytomaAnaplastic AstrocytomaGlioblastoma
Sun Yat-sen University 100
Early research (Phase 1)Study completedNCT01172964
What this trial is testing

A Pilot Feasibility Study of Oral 5-Fluorocytosine and Genetically-Modified Neural Stem Cells Expressing E.Coli Cytosine Deaminase for Treatment of Recurrent High Grade Gliomas

Who this might be right for
Adult Anaplastic AstrocytomaRecurrent Grade III GliomaRecurrent Grade IV Glioma+9 more
City of Hope Medical Center 15
Load More Results